Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-02

Clinical Trial Update: A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating umbilical cord mesenchymal stem cell exosomes for androgenetic alopecia in young men; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Mesenchymal Stem Cell Exosomes (umbilical cord-derived mesenchymal stem cell exosomes)

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Androgenic Alopecia | Phase 1, Phase 2 | Status: RECRUITING